The clinical value of MRI using single-shot echoplanar DWI to identify liver involvement in patients with advanced gastroenteropancreatic-neuroendocrine tumors (GEP-NETs), compared to FSE T2 and FFE T1 weighted image after i.v. Gd-EOB-DTPA contrast enhancement

Medical Science Monitor

Volumn 18, Issue 5, 2012, Pages

  Sankowski, Artur J ^a   Ćwikła, Jarosław B ^b   Nowicki, Mirosław L ^a   Chaberek, Sławomir ^c   Pech, Maciej ^d   Lewczuk, Anna ^e   Walecki, Jerzy ^f  

^a Ministry of Interior and Administration Republic of Poland Central Clinical Hospital   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^c Indepentent Public Clinical Hospital   (Poland)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e POLISH ACADEMY OF SCIENCES   (Poland)

^f MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Advanced GEP NET (gastroenteropancreatic neuroendocrine tumors); Liver deposits; MR DWI

Indexed keywords

GADOXETIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; FEMALE; FOLLOW UP; GASTROENTEROPANCREAS NEUROENDOCRINE TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS NEUROENDOCRINE TUMOR; PROSPECTIVE STUDY;

EID: 84860651877     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882719     Document Type: Article

References (28)

1. Caplin ME, Buscombe JR, Hilson AJ et al: Carcinoid tumour. Lancet, 1998; 352: 799-805
2. Plöckinger U, Rindi R, Arnold R et al: Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours Neuroendocrinology, 2004; 80: 394-424
3. Kloeppel G, Rindi G, Anlauf M et al: Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumours Virchows Archive, 2007; 451: S9-S27
4. Eriksson B, Kloeppel G, Krenning EP et al: Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours - Well Differentiated Jejunal - Ileal Tumor/Carcinoma Neuroendocrinology, 2008; 87: 8-19
5. Ćwikla JB, Nasierowska-Guttmejer A, Jeziorski KG et al: Algorytm diagnostyczny guzów neuroendokrynnych układu pokarmowego (GEP - NET) i oskrzela. Pol J Radiol, 2005; 70: 85-92 [in Polish]
6. Sundin A, Vullierme MP, Kaltsas G et al: ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: radiological examinations Neuroendocrinology, 2009; 20: 167-183
7. Kwekkeboom DJ, de Herder WW, Kam BL et al: Treatment with the Radiolabelled Somatostatine Analog [177Lu-DOTA0Tyr3]octreotate: Toxicity, Efficacy and Survival. J Clin Oncol, 2008; 26: 2124-2130
8. Ćwikła JB, Sankowski AJ, Seklecka N et al: Efficacy of radionuclide treatment 90Y-DOTATATE in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NET). A phase II study. Annals Oncology, 2010; 21: 787-794
9. Sankowski AJ, Ćwikła JB, Nowicki ML et al: Comparison of MRI DWI vs. MRI T1 contrast enhancement using (Gd)-DTPA and (Gd-EOB)-DTPA in detection rate of liver metastasis in patients with advance gastroenteropancreatic-neuroendocrine tumours (GEP-NET). Eur Radiol; Suppl; 2010; Abstract
10. Chrzan R, Sowa-Staszczak A, Tomaszuk M et al: Usefulness of SPECT/CT fusion in the verification of lesions detected in somatostatin receptor scintigraphy and in the evaluation of therapy efficiency in patients with gastroenteropancreatic neuroendocrine tumors. Pol J Radiol, 2009; 74: 29-33
11. Cwikła JB, Buscombe JR, Caplin ME et al: Diagnostic imaging of carcinoid metastases to the abdomen and pelvis. Med Sci Monit, 2004; 10(Suppl.3): 9-16
12. Dromain C, de Baere T, Lumbroso J et al: Detection of liver metastases from endocrine tumours: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol, 2005; 23: 70-78
13. Cwikła JB, Nasierowska-Guttmejer A, Jeziorski K et al: Diagnostic imaging approach to gastroentero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland. Neuroendocrinol Letters, 2007; 28: 789-800
14. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR et al: Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology, 1992; 183: 59-64
15. Vogl TJ, Kuemmel S, Hammerstingl R et al: Liver tumours: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology, 1996; 200: 59-67
16. Parikh T, Drew SJ, Lee VS et al: Focal liver lesions detection and characterization with Diffusion MR Imaging: Comparison with breath hold T2 weighted imaging. Radiology, 2008; 246: 812-822
17. Taouli B, Vilgrain V, Dumont E et al: Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology, 2003; 226: 71-78
18. Danet IM, Semelka RC, Leonardou P et al: Spectrum of MRI appearances of untreated metastases of the liver. AJR, 2003; 181: 809-817
19. Ichikawa T, Haradome H, Hachiya J et al: Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging, 1999; 24: 456-461
20. Touli B, Koh D-M: Diffusion-Weighted MR Imaging of the liver. Radiology, 2010; 254: 47-66
21. Bruegel M, Gaa J, Waldt S et al: Diagnosis of hepatic metastasis: comparison of respirationrespiration- triggered diffusion-weighted echoplanar MRI and five t2-weighted turbo spinecho sequences. AJR, 2008; 191: 1421-1429
22. Landis JR, Koch GG: An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics, 1977; 33: 363-374
23. Coenegrachts K, Delanote J, Ter Beek L et al: Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol, 2007; 80: 524-531
24. Reubi JC, Schar JC, Waser B et al: Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med, 2000; 27: 273-282
25. Huppertz A, Balzer T, Blakeborough A et al: Improved detection of focal liver lesions at MR Imaging: Multicenter Comparison of Gadoxetic Acid-enhanced MR Images with Intraoperative Findings. Radiology, 2004; 230: 266-275
26. Denecke T, Rühl R, Hildebrandt B et al: Planning transarterial radioembolization of colorectal liver metastases with Yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques. Eur Radiol, 2008; 18: 892-902
27. Wiggermann Ph, Sieron D, Brosche Ch et al: Transarterial Chemoembolization of Child-A hepatocellular carcinoma: Drug eluting bead TACE (DEB TACE) vs. TACE with Cisplatin/Lipidol (cTACE). Med Sci Monit, 2011; 17(4): CR189-CR195
28. Jarzabek M, Jargiełło T, Wolski A et al: Drug-eluting microspheres transarterial chemoembolization (DEM TACE) in patients with liver metastases. Pilot study. Pol J Radiol, 2011; 76(3):26-32